$ALKS 3 SEC Filings

Filed On	Filing
18 Sep 2026	Form 3: Whitaker Anne Clem, Director No securities owned
23 Sep 2025	Form 3: Reed Joshua, SVP, Chief Financial Officer No securities owned
15 Mar 2024	Form 3: Lurker Nancy, Director No securities owned
09 Feb 2024	Form 3: Parisi Samuel Joseph, VP, Finance (Interim PAO) Holds 3,900 shares of Ordinary Shares
31 May 2022	Form 3: Wright Christopher I, Director No securities owned
24 Nov 2021	Form 3: Laurencin Cato T, Director No securities owned
28 May 2021	Form 3: Alva Emily Peterson, Director No securities owned
26 Jan 2021	Form 3: Jackson Blair Curtis, EVP, Chief Operating Officer Holds 58,532 shares of Ordinary Shares
18 Dec 2020	Form 3: Mckeon Brian P, Director No securities owned
18 Dec 2020	Form 3: Daglio David Angelo Jr., Director Holds 45,000 shares of Ordinary Shares
29 May 2020	Form 3: Nichols Christian Todd, SVP, Chief Commercial Officer
24 Sep 2019	Form 3: Wilson Frank Anders, Director No securities owned
24 Sep 2019	Form 3: Gaynor Richard, Director No securities owned
24 Sep 2019	Form 3: Gaynor Richard, Director No securities owned
14 Mar 2018	Form 3: Robinson James A. Jr., President & COO,Alkermes, Inc. No securities owned
09 Feb 2018	Form 3: Hopkinson Craig C., SVP, Med Dev/Med Affairs, CMO
01 Jun 2016	Form 3: Gaffin David Joseph, SVP, CLO, Alkermes, Inc. Holds 19,590 shares of Ordinary Shares
26 May 2016	Form 3: snyderman nancy lynn Md, Director No securities owned
29 May 2015	Form 3: Brown Iain Michael, VP, Finance & CAO Holds 36,428 shares of Ordinary Shares
17 May 2013	Form 3: Wysenski Nancy, Director No securities owned

Comments